[NYC Session] She Started It: A Film Screening

Add this event to your calendar:
29/06/2017 17:30 29/06/2017 20:30 America/New_York [NYC Session] She Started It: A Film Screening New York Genome Center , , New York , NY 10013 Johnson & Johnson Innovation, JLABS false DD/MM/YYYY

[NYC Session] She Started It: A Film Screening

New York Genome Center , , New York , NY 10013

June 29, 2017 from 17:30 PM to 20:30 PM (EST)

$10 - $35

96% of venture capitalists are men1. Women still account for less than 10% of founders for high growth firms2 and earn only 12.9% of computer science degrees3. "She Started It" gives a new face to the image of the tech entrepreneur: a female face.

Join Johnson & Johnson Innovation JLABS for a film screening of "She Started It", a new documentary film that follows five trailblazing young female entrepreneurs through their journeys of entrepreneurship.

View the trailer for the film here. Students and families are welcome to attend.

The movie screening will be followed by a short panel discussion featuring the filmmaker, Nora Poggi, and local influential women in business.

2"Sources of Economic Hope" by Kauffman Foundation
3Computing Research Association study

Event Partners:

(Moderator) Nora Poggi | Director, She Started It read bio»
Marcia Hendrickson | CEO, Mitogenetics read bio»
Maria Luisa Pineda, Ph.D. | CEO, Envisagenics read bio»
Grace Soyao | Founder & CEO, Self Care Catalysts read bio»

4:00 PM | Registration Open & Networking Reception
4:30 PM | Film Screening of "She Started It" - 60 mins
5:30 PM | Panel discussion featuring filmmaker Nora Poggi
6:30 PM | Program Close


$5 | General Public
FREE | Children 12 and under

New York Genome Center
101 6th Ave.
1st Floor
New York, NY 10013

Nora Poggi | Director, Producer
Nora Poggi is a French journalist with a background in film production who has been interviewing key players in Silicon Valley for the past four years. After graduating from French top schools Sciences Po Paris and La Sorbonne, she moved to San Francisco to work for French social network Viadeo.com. She then went back to her first love, films, with the production company Lucky Dragon Productions, where she trained in all areas of film production and promotion. At the same time, she started freelance reporting for Examiner.com on major Silicon Valley events, producing video interviews with tech industry players. She now also writes about entrepreneurship & tech for French newspaper Usine Nouvelle.

Marcia Hendrickson | CEO, Mitogenetics
Marcia Hendrickson has served as the President and Chief Executive Officer of Mitogenetics since January 2013. She also serves as Vice President and partner with Val-Add Ventures, an investment company in Sioux Falls, South Dakota. She brings expertise in several facets including, intellectual property assistance, competitive intelligence, market analysis, financial analysis, strategic development, business planning and capital sourcing. Ms. Hendrickson was the founding Executive Director of the South Dakota Enterprise Institute which served as a virtual incubator for commercialization of research and growth oriented start-up businesses. Ms. Hendrickson has helped launch many successful start-up technology companies. During her tenure as Executive Director of the Enterprise Institute, she also developed an extensive angel network. She was appointed by former South Dakota Governor Rounds to the Value-Added Finance Authority in 2007 and by current Governor Daugaard in 2015 for a third-year term. Marcia graduated from South Dakota State University, Brookings, South Dakota, with a Bachelor of Science in Microbiology and is also a Certified Public Accountant.

Marcia and her husband, Chuck, live near Chancellor, SD. They have three children: Ann Hoffman- Lennox, Katie Daniel-Sioux Falls and Joe Hendrickson-Chancellor.

Maria Luisa Pineda, Ph.D. | CEO, Envisagenics
Dr. Maria Luisa Pineda is currently the CEO and co-founder of Envisagenics, Inc. a bioinformatics start-up company spinout of Cold Spring Harbor Laboratory. She has led the company to obtain paying customers in the field of RNA therapeutics, an SBIR Phase I award from NIH, a pre-seed investment from Accelerate Long Island, the LIET Fund, the Breakout Labs by the Thiel Foundation. Maria is a cell and molecular biologist with over 10 years of research experience. She received her PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory as an Arnold and Mabel Beckman graduate student and a William Randolph Hearst foundation scholar. For her undergraduate studies she graduated from Barry University with a Bachelor of Science and a minor in Mathematics. As an undergraduate student she was able to acquire an endowment of $2 Million dollars from the Goizueta Foundation and lobby the foundation to renew it after her graduation. She was the first recipient of the Goizueta Minority Science Scholarship and was a NIH fellow with the Minority Access to Research Careers (MARC U*STAR) Award. After her doctorate, she decided to combine science and business together with her interpersonal skills by acquiring experience in investment of technology and life sciences startup companies at Canrock Ventures and Golden Seeds, LLC.

Grace Soyao | Founder & CEO, Self Care Catalysts
Grace Soyao, Founder & CEO of Self Care Catalysts is leveraging her more than 20 years of commercial marketing and strategy experience from major Pharmaceutical and Consumer Packaged Goods companies to build a cloud-based patient intelligence, analytics and insights company to empower patients, impact healthcare outcomes through real world behavior evidence that could transform drug development, market access, reimbursement, commercialization and post marketing activities.

She leads, mentor and drives a high-performing team that builds a highly challenging but inspiring environment that fosters a culture of entrepreneurship, innovation, creativity and commercialization

Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), New York City, and with Shanghai opening in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact

Related content